Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.5670
-0.0700 (-10.99%)
At close: Jul 25, 2025, 4:00 PM
0.5651
-0.0019 (-0.34%)
After-hours: Jul 25, 2025, 7:54 PM EDT
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2024. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,366,412
Market Cap
17.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17 | -1 | -5.56% |
Dec 31, 2023 | 18 | -1 | -5.26% |
Dec 31, 2022 | 19 | 2 | 11.76% |
Dec 31, 2021 | 17 | 2 | 13.33% |
Dec 31, 2020 | 15 | -1 | -6.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBRX News
- 4 days ago - Moleculin Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference - GlobeNewsWire
- 9 days ago - Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships - GlobeNewsWire
- 17 days ago - Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans - GlobeNewsWire
- 4 weeks ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 5 weeks ago - Moleculin Announces $5.9 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Moleculin Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 5 weeks ago - Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML - GlobeNewsWire
- 7 weeks ago - Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107) - GlobeNewsWire